Skip to main content
. 2010 Mar-Apr;2(2):129–136. doi: 10.4161/mabs.2.2.11221

Table 4.

Surgically relevant complication in the gastric cancer study (minimal residual disease)

Complication Surgery alone n (%) Surgery + catumaxomab n (%)
Anastomosis insufficiency 2 (7.4) 1 (3.7)
Wound healing disorders 2 (7.4) 3 (10.7)
Infections 3 (11.1) 4 (14.3)
Abdominal abscess 1 (3.7) 0